Alchemab is an England-based biotechnology company that researches and develops antibody therapeutics for the treatment of cancer and neurodegenerative diseases.
Business Model:
Revenue: $2.1M
Employees: 11-50
Address: East Side, Office 1.02
City: London
State: england
Zip: N1C 4AX
Country: GB
Alchemab is an England-based biotechnology company that researches and develops antibody therapeutics for the treatment of cancer and neurodegenerative diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2021 | Series A | 6 | $82.7M |
DCVC Dementia Discovery Fund DHVC Lightstone Ventures RA Capital Management SV Health Investors DCVC Dementia Discovery Fund DHVC Lightstone Ventures RA Capital Management SV Health Investors |
12/2022 | Grant | 1 | $2.1M |
Biomedical Catalyst Fund Biomedical Catalyst Fund |
6/2020 | Venture Round | $224k | 4/2021 | Series A | $82M |
RA Capital Management Lightstone Ventures Data Collective VC SV Health Investors |
12/2019 | Seed | - | 12/2019 | Seed Round | 1 | - |
DCVC Bio DCVC Bio DCVC Bio DCVC Bio |
3/2021 | Grant | $2.2M |
Medicines Discovery Catapult |
12/2019 | Seed | - |
SV Health SV Health |
12/2019 | Seed Round | 1 | - |
DCVC Bio DCVC Bio DCVC Bio DCVC Bio |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|